Oops! Something went wrong, please try again later.
Centessa Pharmaceuticals is discontinuing the clinical development of SerpinPC, its experimental under-the-skin therapy for people with hemophilia A …
Gene therapy for hemophilia B is an approved treatment with potential to be given as a one-time infusion. It addresses the underlying cause of hemophilia B by providing the...